ArticleFrontiers in genetics2022

MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.